~~<i id='D75C4A00CE'><strike id='D75C4A00CE'><tt id='D75C4A00CE'><pre id='D75C4A00CE'></pre></tt></strike></i>~~

Home» Wikipedia» knowledge

knowledge

author：comprehensive 2025-10-01 14:31:48 Page View：5914

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA panel to weigh safety of artificial wombs for preterm births
Next article： How one medical school became remarkably diverse

knowledge

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

FDA panel to weigh safety of artificial wombs for preterm births

AdobeTheartificialwomb,adeviceaimingtosaveinfantsbornwaytoosoon,isinchingclosertobeingtestedinhumans

Jerome Adams on the need for new antivirals for Covid

PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

Removing probiotics from the NICU could threaten preemies' health

MicahCanvasser'stragicdeathonemonthbeforehisfirstbirthdayhasinspiredhismothertofightnecrotizingenter

WSS

knowledge

knowledge

explore

knowledge

Removing probiotics from the NICU could threaten preemies' health